In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.
Browsing: Disease Discoveries
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.
Northwestern Medicine scientists showed how the overexpression of the protein SNRK in cardiac tissue improves cardiac metabolism and is protective against ischemic conditions.
A new review, published in Nature Reviews Neurology, outlines how upper motor neuron degeneration is an important feature in ALS pathology, and could be key to developing better diagnostic tools and treatments for ALS.
A surgical procedure called a pelvic exenteration may be curative for more than half of women with a form of advanced cervical cancer who have failed other treatments.
A Northwestern Medicine study uncovered novel findings about sodium channels in neurons that may represent a novel therapeutic target for epilepsy treatment.
Northwestern Medicine scientists and co-authors defined a role for the WAVE1 protein in the cellular mechanisms behind cocaine addiction.
Northwestern Medicine scientists have identified a molecular therapy to prevent the growth of a rare pediatric leukemia.
A recent study explores the use of metabolic markers to target ovarian cancer stem cells and could improve outcomes of existing therapies.
Northwestern Medicine scientists have identified a link between Huntington’s disease and dysfunction of the subthalamic nucleus, a component of the basal ganglia, a group of brain structures critical for movement and impulse control.